Clinical Trials Browser

Phase 3 × Breast Neoplasms × Drug Therapy × Clear all

NCT06195709 2025-12-18

ECLECTIC

Phase 3 Recruiting

Breast Neoplasms, Neoplasm Metastasis

NCT07005557 2025-06-05

SENIOR

Phase 3 Not yet recruiting

Breast Neoplasms

NCT06341621 2024-04-10

Rainbow

Phase 3 Recruiting

Breast Neoplasms

NCT00004935 2023-04-18

Herceptin Followed by Chemotherapy in Treating Women With Metastatic Breast Cancer That Overexpresses HER2

Phase 3 Terminated

Breast Neoplasms

NCT05346861 2022-04-26

Pyrotinib Rechallenge in Her2-positive Metastatic Breast Cancer Pretreated With Pyrotinib and Trastuzumab

Phase 3 Unknown

Breast Neoplasms

NCT02535221 2021-11-29

Neoadjuvant Endocrine Therapy Versus Chemotherapy in Premenopausal Patients With ER+ & HER2- Breast Cancer

Phase 3 Recruiting

Breast Neoplasms

NCT01104935 2019-10-21

RESPECT

Phase 3 Completed

Breast Neoplasms

NCT01796444 2018-04-05

Z0011-China

Phase 3 Withdrawn

Breast Neoplasms

NCT00382018 2017-11-06

S0500 Treatment Decision Making Based on Blood Levels of Tumor Cells for Metastatic Breast Cancer Treated With Chemo

Phase 3 Completed

624 enrolled 12 charts

Breast Neoplasms

NCT00074152 2017-06-16

CALOR

Phase 3 Completed

162 enrolled 17 charts

Breast Neoplasms

NCT00448279 2014-10-24

THOR Study: A Study of Continued Herceptin (Trastuzumab) in Combination With Second Line Chemotherapy in Patients With HER2 Positive Metastatic Breast Cancer.

Phase 3 Completed

58 enrolled 11 charts

Breast Neoplasms

NCT00262067 2013-12-13

A Study Evaluating the Efficacy and Safety of Bevacizumab in Combination With Chemotherapy in Untreated Metastatic Breast Cancer (RIBBON 1)

Phase 3 Unknown

1,237 enrolled 14 charts

Breast Neoplasms

NCT01622361 2013-09-30

NEST

Phase 3 Unknown

Breast Neoplasms

NCT00639366 2013-08-07

Radiation Therapy to the Head in Preventing Brain Metastases in Women Receiving Trastuzumab and Chemotherapy for Metastatic or Locally Advanced Breast Cancer

Phase 3 Completed

Breast Neoplasms

NCT00403182 2012-06-01

Chemotherapy and Hormone Therapy as First-Line Therapy in Treating Postmenopausal Women With Metastatic or Locally Advanced Breast Cancer

Phase 3 Withdrawn

Breast Neoplasms